Arne Jahn

1.0k total citations
19 papers, 148 citations indexed

About

Arne Jahn is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Arne Jahn has authored 19 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in Arne Jahn's work include Pancreatic and Hepatic Oncology Research (4 papers), Cancer Genomics and Diagnostics (4 papers) and Genomics and Rare Diseases (3 papers). Arne Jahn is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Cancer Genomics and Diagnostics (4 papers) and Genomics and Rare Diseases (3 papers). Arne Jahn collaborates with scholars based in Germany, Singapore and Spain. Arne Jahn's co-authors include W. Gottschalk, Evelin Schröck, Arturo Londoño‐Vallejo, Irena Drašković, Frank Buchholz, Nataliya Di Donato, Andreas Tzschach, Maciej Paszkowski‐Rogacz, Sergi Sayols and Grishma Rane and has published in prestigious journals such as The EMBO Journal, PLoS ONE and EMBO Reports.

In The Last Decade

Arne Jahn

17 papers receiving 143 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arne Jahn Germany 7 69 40 29 26 22 19 148
Lea Velsher Canada 8 61 0.9× 91 2.3× 20 0.7× 14 0.5× 10 0.5× 18 181
Vinh Trương France 6 87 1.3× 61 1.5× 31 1.1× 7 0.3× 11 0.5× 9 177
Lorette O. M. Hulsman Netherlands 7 66 1.0× 53 1.3× 10 0.3× 12 0.5× 14 0.6× 9 140
Wagner Antonio da Rosa Baratela Brazil 8 61 0.9× 62 1.6× 32 1.1× 9 0.3× 5 0.2× 14 153
Helena Raurell‐Vila Spain 5 190 2.8× 68 1.7× 28 1.0× 24 0.9× 16 0.7× 5 299
Luisina Ongaro Canada 11 153 2.2× 63 1.6× 32 1.1× 17 0.7× 4 0.2× 27 289
John Lazar United States 5 230 3.3× 38 0.9× 20 0.7× 7 0.3× 15 0.7× 7 274
Marjolein P. Baar Netherlands 5 157 2.3× 18 0.5× 57 2.0× 25 1.0× 6 0.3× 5 223
Masataka Hirasaki Japan 10 230 3.3× 37 0.9× 11 0.4× 18 0.7× 17 0.8× 36 300
A. Pohl United States 2 219 3.2× 44 1.1× 15 0.5× 14 0.5× 17 0.8× 2 275

Countries citing papers authored by Arne Jahn

Since Specialization
Citations

This map shows the geographic impact of Arne Jahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arne Jahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arne Jahn more than expected).

Fields of papers citing papers by Arne Jahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arne Jahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arne Jahn. The network helps show where Arne Jahn may publish in the future.

Co-authorship network of co-authors of Arne Jahn

This figure shows the co-authorship network connecting the top 25 collaborators of Arne Jahn. A scholar is included among the top collaborators of Arne Jahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arne Jahn. Arne Jahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Widmann, Thomas J., Karl Hackmann, Sylke Winkler, et al.. (2025). Long-read genome and RNA sequencing resolve a pathogenic intronic germline LINE-1 insertion in APC. npj Genomic Medicine. 10(1). 30–30. 1 indexed citations
2.
Jahn, Arne, Vineeth Thachappilly Mukundan, Yunyu Shi, et al.. (2024). ZBTB48 is a priming factor regulating B-cell-specific CIITA expression. The EMBO Journal. 43(24). 6236–6263. 2 indexed citations
3.
Funk, Alexander, Mirko Peitzsch, Svenja Nölting, et al.. (2024). Identification of Succinate Dehydrogenase Gene Variant Carriers by Blood Biomarkers. Journal of the Endocrine Society. 8(9). bvae142–bvae142. 6 indexed citations
4.
Friedrich, Ulrike, Arne Jahn, Carolin Walter, et al.. (2023). A clinical screening tool to detect genetic cancer predisposition in pediatric oncology shows high sensitivity but can miss a substantial percentage of affected children. Genetics in Medicine. 25(8). 100875–100875. 2 indexed citations
5.
Teleanu, Maria‐Veronica, Carmina Teresa Fuß, Nagarajan Paramasivam, et al.. (2023). Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling. Molecular Oncology. 17(7). 1343–1355. 7 indexed citations
6.
Jahn, Arne, Katharina Heller, Mario Schiffer, et al.. (2022). Peculiarities in the panoramic radiograph of patients with secondary hyperparathyroidism due to terminal renal disease: a radiologic controlled comparative study. Oral Radiology. 39(1). 125–132. 2 indexed citations
7.
Hanf, Dorothea, Christoph Heining, Sebastian Uhrig, et al.. (2021). Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient WithETV6-NTRK3Fusion-Positive Carcinoma Harboring theNTRK3G623RSolvent-Front Mutation. JCO Precision Oncology. 5(5). 687–694. 4 indexed citations
8.
Lutz, Rainer, Arne Jahn, Katharina Heller, et al.. (2021). Frequency of the necessity of dentoalveolar surgery or conservative treatment in patients before kidney transplantation depending on the duration of dialysis and causative nephrological disease. Clinical Oral Investigations. 26(3). 2383–2390. 1 indexed citations
9.
10.
Kast, Karin, et al.. (2021). Recommendation and Acceptance of Counselling for Familial Cancer Risk in Newly Diagnosed Breast Cancer Cases. Breast Care. 17(2). 153–158. 1 indexed citations
11.
Berger, Anne, Sadaf S. Mughal, Michael Allgäuer, et al.. (2020). Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare disease. Pancreatology. 20(3). 425–432. 17 indexed citations
12.
Porrmann, Joseph, Andreas Rump, Karl Hackmann, et al.. (2018). Novel truncating PPM1D mutation in a patient with intellectual disability. European Journal of Medical Genetics. 62(1). 70–72. 6 indexed citations
13.
Alter, Svenja, Alrun Hotz, Arne Jahn, et al.. (2018). Novel VPS33B mutation in a patient with autosomal recessive keratoderma‐ichthyosis‐deafness syndrome. American Journal of Medical Genetics Part A. 176(12). 2862–2866. 8 indexed citations
14.
Gieldon, Laura, Luisa Mackenroth, Anne‐Karin Kahlert, et al.. (2018). Diagnostic value of partial exome sequencing in developmental disorders. PLoS ONE. 13(8). e0201041–e0201041. 29 indexed citations
15.
Jahn, Arne, Grishma Rane, Maciej Paszkowski‐Rogacz, et al.. (2017). ZBTB 48 is both a vertebrate telomere‐binding protein and a transcriptional activator. EMBO Reports. 18(6). 929–946. 38 indexed citations
16.
Jahn, Arne, et al.. (2016). Survey on Current Postnatal Surgical Management of Myelomeningocele in Germany. Journal of Neurological Surgery Part A Central European Neurosurgery. 77(6). 489–494. 2 indexed citations
17.
Martin, Janet, et al.. (2013). Successful surgical separation of conjoined twins: First experience in Rwanda. TSpace. 18(1). 124–129. 1 indexed citations
18.
Jahn, Arne, et al.. (2012). A Survey on Current Practice in the Neurosurgical Management of Preterm Infants with Posthemorrhagic Hydrocephalus in Germany. Journal of Neurological Surgery Part A Central European Neurosurgery. 74(2). 82–86. 4 indexed citations
19.
Gottschalk, W. & Arne Jahn. (1964). Cytogenetische Untersuchungen an desynaptischen und m�nnlich-sterilen Mutanten vonPisum. Molecular Genetics and Genomics. 95(2). 150–166. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lea Velsher Breakdown of academic impact, for papers by Vinh Trương Breakdown of academic impact, for papers by Lorette O. M. Hulsman Breakdown of academic impact, for papers by Wagner Antonio da Rosa Baratela Breakdown of academic impact, for papers by Helena Raurell‐Vila Breakdown of academic impact, for papers by Luisina Ongaro Breakdown of academic impact, for papers by John Lazar Breakdown of academic impact, for papers by Marjolein P. Baar Breakdown of academic impact, for papers by Masataka Hirasaki Breakdown of academic impact, for papers by A. Pohl
Rankless by CCL
2026